Published in Immunotherapy Weekly, June 22nd, 1998
Researchers from the John Wayne Cancer Institute, California, conducted a phase II trial of PMCV in stage IV melanoma patients. Eddy C. Hsueh represented colleagues and reported the trial findings at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Correlation of Specific Immune Responses with Survival in AJCC Stage IV Melanoma Patients Receiving Polyvalent Melanoma Cell Vaccine").
"We hypothesized a correlation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.